Ortho­cell takes off

Townsville Bulletin - - NEWS -

SHARES in biotech Ortho­cell have soared af­ter a lead­ing sci­en­tific pub­li­ca­tion pub­lished data on Ortho­cell’s col­lab­o­ra­tive re­search on re­gen­er­at­ing car­ti­lage. Yesterday, Ortho­cell was up 8.5c, or 18.28 per cent, at 55c. Ortho­cell is de­vel­op­ing cell- based ther­a­pies that aim to re­gen­er­ate dam­aged ten­don and car­ti­lage tis­sue. Its projects in­clude the fab­ri­ca­tion of hu­man ten­don out­side of the body for full ten­don re­place­ment. Perth­based Ortho­cell says pub­li­ca­tion of the re­search data fur­ther val­i­dates its prod­ucts de­rived from cells cul­ti­vated in a “cell fac­tory”.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.